An additional 420 000 Moderna vaccines are expected to be obtained by Latvia in the second half of the year. It is needed to be safe that there will be no shortage of vaccines in the country if the supply of any other vaccines would be delaye.
In total, within a year, Latvia plans to purchase 546 900 doses from Moderna, which would allow 273 450 people to be vaccinated.
Pavluts said that the government also expressed interest in two new vaccines, the American company Novavax, which is likely to be expected by the middle of the year, and the Swedish Valneva. There are no clear predictions yet about the development of the latter company's vaccines. The European Commission has concluded pre-emptive contracts with companies.
For the purchase, logistics and vaccination of vaccines, the government has provided a maximum amount of EUR 14.3 million.
According to the plan developed by the Ministry of Health, it is planned to vaccinate 70% of the adult population of Latvia by the end of summer, providing 100 000-150 000 vaccination per week.
